In our earlier studies, we found that patients with secondary immunodeficiency states due to hematological malignancies and end-stage renal disease had decreased serum antibody levels to protein D, one of the well-characterized protective NTHi antigens included in a pediatric vaccine Synflorix [52]. This evidence concerns the gene DHRS2 and chronic kidney disease.